Search results for "EPA"

showing 10 items of 8995 documents

The use of infliximab in pediatric ulcerative colitis: A retrospective survey

2006

medicine.medical_specialtyHepatologybusiness.industryRetrospective surveyInternal medicineGastroenterologyMedicinePediatric ulcerative colitisbusinessInfliximabmedicine.drugDigestive and Liver Disease
researchProduct

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG study

2010

Acute hepatitis C continues to be a concern in men who have sex with men (MSM), and its optimal management has yet to be established. In this study, the clinical, biological, and therapeutic data of 53 human immunodeficiency virus (HIV)-infected MSM included in a multicenter prospective study on acute hepatitis C in 2006-2007 were retrospectively collected and analyzed. The mean hepatitis C virus (HCV) viral load at diagnosis was 5.8 ± 1.1 log10 IU/mL (genotype 4, n = 28; genotype 1, n = 14, genotype 3, n = 7). The cumulative rates of spontaneous HCV clearance were 11.0% and 16.5% 3 and 6 months after diagnosis, respectively. Forty patients were treated, 38 of whom received pegylated interf…

medicine.medical_specialtyHepatologybusiness.industryRibavirinHepatitis C virusvirus diseasesHepatitis CHepatologymedicine.diseasemedicine.disease_causeGastroenterologydigestive system diseasesMen who have sex with menchemistry.chemical_compoundchemistryPegylated interferonInternal medicineImmunologymedicineProspective cohort studybusinessViral loadmedicine.drugHepatology
researchProduct

Early menopausal status is associated with the severity of liver fibrosis in Italian patients with non-alcoholic fatty liver disease

2014

medicine.medical_specialtyHepatologybusiness.industrySettore MED/12 - GASTROENTEROLOGIALiver fibrosisFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseGastroenterologyInternal medicinemedicinebusinessDigestive and Liver Disease
researchProduct

Visceral adiposity index and exercise in non-alcoholic fatty liver disease: authors’ reply

2012

We thank Prof. Filik for his interest in our recent article. 2 He points to the fact that the interpretation of our results could be affected by lack of data on physical activity and diet. In response to this issue, we are aware that both physical activity and diet are able to affect not only anthropometric and metabolic parameters of visceral adiposity index (VAI) but also the severity of liver disease. Unfortunately, data on both physical activity and diet in our patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD) are not available, even if we are confident that their variations should not significantly affect our results. In fact, in our study, we evaluated histological…

medicine.medical_specialtyHepatologybusiness.industrySurrogate endpointFatty liverGastroenterologyNon alcoholicDiseaseAnthropometrymedicine.diseaseGastroenterologyLiver diseaseEndocrinologyInternal medicineMedicinePharmacology (medical)Liver damagebusinessMETABOLIC FEATURESAlimentary Pharmacology & Therapeutics
researchProduct

Obstrucción funcional de la unión esofagogástrica inducida por opiáceos

2017

medicine.medical_specialtyHepatologybusiness.industryTransdermal patchGastroenterologyGastroenterology03 medical and health sciences0302 clinical medicineTratamiento farmacologicoText miningOpioid030220 oncology & carcinogenesisInternal medicinemedicineEsophageal sphincter030211 gastroenterology & hepatologyEsophageal spasmEsophagogastric junctionbusinessmedicine.drugGastroenterología y Hepatología
researchProduct

Treatment of chronic hepatitis C

1991

alpha-Interferon given subcutaneously at doses between 1-3 million units leads to responses in about 50% of patients suffering from chronic hepatitis C. A 24-week treatment is frequently (approx. 50%) followed by relapses reducing the percentage of lasting responders to approx. 20%. The patients who relapse are sensitive to retreatment with interferon-alpha. A better understanding of HCV replication and of the interferon action in this viral disease might help to further improve treatment schedules. Side effects of interferon were frequently mild and readily reversible after cessation of treatment. At present interferon treatment should not be recommended in asymptomatic patients or individ…

medicine.medical_specialtyHepatologybusiness.industryTreatment outcomeInterferon-alphaHepacivirusVirus ReplicationProgressive liver diseaseHepatitis CAsymptomaticGastroenterologyTreatment OutcomeViral replicationChronic hepatitisInterferonInternal medicineChronic DiseaseImmunologyHumansMedicineViral diseaseMillion Unitsmedicine.symptombusinessmedicine.drugJournal of Hepatology
researchProduct

Murine genetic deficiency of neuronal nitric oxide synthase (nNOS-/-) and interstitial cells of Cajal (W/Wv): Implications for achalasia?

2014

Background and aim Nitric oxide (NO) is an important inhibitory mediator of esophageal function, and its lack leads to typical features of achalasia. In contrast, the role of intramuscular interstitial cells of Cajal (ICC-IM) and vasoactive intestinal peptide (VIP) in lower esophageal sphincter (LES) function is still controversial. Therefore, we examined the function and morphology of the LES in vivo in NO-deficient (nNOS(-/-) ), ICC-IM-deficient (W/W(v) )-, and wild-type (WT) mice. Methods Esophageal manometry was performed with a micro-sized transducer catheter to quantify LES pressure, swallow evoked LES relaxation, and esophageal body motility. The LES morphology was examined by semiqu…

medicine.medical_specialtyHepatologybusiness.industryVasoactive intestinal peptideGastroenterologyMotilityAchalasiaInhibitory postsynaptic potentialmedicine.diseaseNitric oxideInterstitial cell of Cajalchemistry.chemical_compoundsymbols.namesakeEndocrinologychemistryIn vivoInternal medicineotorhinolaryngologic diseasesmedicinesymbolsbusinessNeuronal Nitric Oxide SynthaseJournal of Gastroenterology and Hepatology
researchProduct

Tu1320 Personality Traits, Defense Mechanisms and Perception of Quality of Life (QOL) in Patients With Inflammatory Bowel Disease (IBD) and Matched C…

2012

medicine.medical_specialtyHepatologybusiness.industrymedia_common.quotation_subjectGastroenterologyDefence mechanismsmedicine.diseaseInflammatory bowel diseaseQuality of lifePerceptionMedicinePersonalityIn patientBig Five personality traitsbusinessPsychiatrymedia_commonGastroenterology
researchProduct

Thyroid ectopia of the liver: An unusual diagnosis with contrast-enhanced EUS (with video)

2019

No abstract available

medicine.medical_specialtyHepatologybusiness.industrymedia_common.quotation_subjectThyroidGastroenterologyMEDLINE.Text miningmedicine.anatomical_structuremedicineContrast (vision)Radiology Nuclear Medicine and imagingRadiologybusinessmedia_commonImages and Videos
researchProduct

Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward

2015

Gastric cancer remains one of the most common malignancies worldwide. Despite the significant advances in surgical treatment and multimodality strategies, prognosis has modestly improved over the last two decades. Locoregional relapse remains one of the main issues and the combined chemoradiation treatment seems to be one of the preferred approaches. However, more than ten years after the hallmark INT-0116 trial, minimal progress has been made both in terms of effectiveness and toxicity. Moreover, new regimens added to combined therapy failed to prove favourable results. Herein, we attempt a thorough literature review comparing pros and cons of all relative studies and potential bias, targe…

medicine.medical_specialtyHepatologybusiness.industrymedicine.medical_treatmentGastroenterologyAlternative medicineMEDLINECancerReview ArticleHepatologyBioinformaticsmedicine.diseaseHepatology; GastroenterologyInternal medicinemedicineCombined therapylcsh:Diseases of the digestive system. GastroenterologyHuman medicinelcsh:RC799-869Intensive care medicinebusinessSurgical treatmentAdjuvantGastroenterology Research and Practice
researchProduct